Navigation Links
MedShape, Inc. Awarded U.S. Patent for Deploying Shape Memory Polymer Devices in Medical Applications
Date:12/15/2011

ATLANTA, Dec. 15, 2011 /PRNewswire/ -- MedShape, Inc., the industry leader in innovative shape memory orthopedic devices, today announced that it has been granted a patent from the United States Copyright and Patent Office for its innovative shape memory polymer based technology. The patent, U.S. Patent No. 8,069,858, was granted December 6, 2011 for a "Method and Apparatus for Deploying a Shape Memory Polymer."

Shape memory polymers are advanced materials that can "remember" more than one shape and transition easily between those shapes with minimal force and without loss of mechanical integrity. Shape-changing polymer medical devices offer advantages over traditional medical devices. They can be inserted into the surgical site in a temporary, compact geometry and then be triggered to deploy into a different, permanent geometry to achieve a specific surgical goal, such as fixation of suture or soft tissue to bone. Unlike traditional static implants, shape memory devices can adapt to changes in the site of implantation, such as local bone resorption, and can respond positively to implant loading to maintain secure fixation even under challenging conditions.

Devices manufactured from MedShape's primary shape memory biopolymer, PEEK Altera®, have already been cleared by the United States Food and Drug Administration for human use. These devices include the Morphix® Suture Anchor and the ExoShape® Soft Tissue Fastener. PEEK Altera was developed by MedShape to allow the design and manufacture of unique shape-changing medical devices with excellent biocompatibility, long-term biostability and uncompromised postoperative imaging options.

"This latest issued patent is a key addition to our intellectual property portfolio and serves to consolidate the leadership position created by MedShape in the field of shape memory biopolymer medical devices," stated Ken Gall, Ph.D., chief technology officer. "MedShape has successfully introduced new shape memory biopolymer devices that deliver tangible benefits to surgeons and patients. This patent recognizes the proprietary nature of our platform technology and is a testament to MedShape's world class research and development team."

About MedShape, Inc.:

MedShape, Inc. is a privately held medical device company working to develop and commercialize a portfolio of surgical solutions that use its patented shape memory technologies to address the increasing demand for improved sports medicine, joint fusion and musculoskeletal trauma products. For more information visit www.medshape.com.

ExoShape, PEEK Altera, MORPHIX are registered trademarks of MedShape, Inc.

Media Contact:
Jenn Harrison
Carabiner Communications
678.313.3438
jharrison@carabinerpr.com

 

 


'/>"/>
SOURCE MedShape, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
2. Federal Funding Awarded to Test Antimicrobial Properties of Copper Metals
3. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
4. Nobel Prize Awarded to Foundation for Biomedical Research Board Member
5. National Jewish, Brigham and Womens Awarded $37 Million to Identify Genes and Other Risk Factors that Influence the Development of COPD
6. SAIC Awarded Malaria Vaccine Production Support Contract Extension by the National Institute of Allergy and Infectious Diseases
7. Congressional Funds Awarded for Testing of Antimicrobial Copper Metals
8. DiObex, Inc. Awarded Patent for the Prevention of Insulin-Induced Hypoglycemia
9. Fundamental Applied Biology, Inc. Is Awarded SBIR Phase IIB Grant for the Commercialization of Protein Therapeutics Using Cell Free Technology
10. New Patent Awarded for Antigen-Sparing Vaccines that Elicit Robust Immunity
11. TriLink Awarded a Phase II Grant for a Second Hot Start PCR Project
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016   TriNetX ... Nationwide Children,s Hospital signed a membership ... accelerate the development of new cures. ... representing over 57 million patients globally, biopharmaceutical companies ... together to improve protocol design, site selection, patient ...
(Date:12/8/2016)... HARRISBURG, Pa. , Dec. 8, 2016 /PRNewswire-USNewswire/ ... and Secretary of Drug and Alcohol Programs ... anxiety and insomnia medications, known as benzodiazepines, developed ... "Benzodiazepines are medications that are frequently ... "However, when they are used with opioid pain ...
(Date:12/8/2016)... 2016  A new study by a pair of ... opioid therapy to treat chronic pain is not only ... harmful consequences, including death. Palliative care physicians ... Mehta , M.D., authored the study which provides a ... The study was published in the December 2016 edition ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... December 09, 2016 , ... The Justin Veatch ... Inc. (NCADD) is recommending the film Whispering Spirits and its discussion ... of Columbia as an education tool in the war against teen drug abuse. ...
(Date:12/9/2016)... NJ (PRWEB) , ... December 09, 2016 , ... ... Founders Ball at The Pierre Hotel in New York, NY, on December 3rd, ... benefactors, dignitaries and physicians attended the annual event, which raised over $1 million ...
(Date:12/8/2016)... ... December 08, 2016 , ... The West Virginia Medical ... 2017. The name change aligns the entire company with its existing Quality ... quality. , “We are very proud of the achievements associated with the West ...
(Date:12/8/2016)... ... 08, 2016 , ... ZyDoc , a New York-based ... Data Capture Methods for Input to Electronic Health Records: A Comparative Usability Study” ... comparative usability study demonstrate that a dictation-based method (“NLP Entry”) using ZyDoc’s MediSapien™ ...
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand ... “What’s In Your Mouth?” (WIYM) campaign to inform dentists and patients about the safety ... dental implant and prosthetic market in the U.S. is projected to reach $6.4 billion ...
Breaking Medicine News(10 mins):